Abstract
Melanoma is the most aggressive and lethal type of skin cancer, with a poor prognosis because of the potential for metastatic spread. The aim was to develop innovative powder formulations for the treatment of metastatic melanoma based on micro- and nanocarriers containing 5-fluorouracil (5FU) for pulmonary administration, aiming at local and systemic action. Therefore, two innovative inhalable powder formulations were produced by spray-drying using chondroitin sulfate as a structuring polymer: (a) 5FU nanoparticles obtained by piezoelectric atomization (5FU-NS) and (b) 5FU microparticles of the mucoadhesive agent Methocel™ F4M for sustained release produced by conventional spray drying (5FU-MS). The physicochemical and aerodynamic were evaluated in vitro for both systems, proving to be attractive for pulmonary delivery. The theoretical aerodynamic diameters obtained were 0.322 ± 0.07 µm (5FU-NS) and 1.138 ± 0.54 µm (5FU-MS). The fraction of respirable particles (FR%) were 76.84 ± 0.07% (5FU-NS) and 55.01 ± 2.91% (5FU-MS). The in vitro mucoadhesive properties exhibited significant adhesion efficiency in the presence of Methocel™ F4M. 5FU-MS and 5FU-NS were tested for their cytotoxic action on melanoma cancer cells (A2058 and A375) and both showed a cytotoxic effect similar to 5FU pure at concentrations of 4.3 and 1.7-fold lower, respectively.
Highlights
Cutaneous melanoma is the most aggressive skin cancer, which starts as an injury restricted to the most superficial layers of the skin [1]
The objective of this work was to develop novel formulations designed to treat advanced metastatic melanoma based on micro- and nanoparticles of 5FU for pulmonary delivery
2018, the objective of this work was to develop novel formulations designed to treat advanced metastatic melanoma based on micro- and nanoparticles of 5FU for pulmonary delivery
Summary
Cutaneous melanoma is the most aggressive skin cancer, which starts as an injury restricted to the most superficial layers of the skin [1]. The principal treatment is based on surgical removal, which offers good chances of patient survival [2]. In advanced stages, melanoma exhibits rapid growth, high potential of metastatic spread and high lethality [3]. Nanomaterials 2018, 8, 75 referred to as metastatic melanoma (MM), cancer cells are widespread in the body, reaching remote areas such as the lungs, liver, bones and brain [4]. In this case, the treatment involves immunotherapy, chemotherapy and targeted therapy, but these options are limited and ineffective in most cases [5].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
